VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BBNXBeta Bionics, Inc.
$16.82$750M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBBNXQuarterly Cash Flow

Beta Bionics, Inc. (BBNX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Beta Bionics, Inc. (BBNX) quarterly cash flow statement — complete operating, investing & financing history

BBNX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q1'24Q4'23
Cash from Operations-23.83M0-8.73M-13.59M-19.98M-14.28M-9.61M-12.14M-6.35M
Operating CF Margin %-86.27%--32.03%-58.5%-113.24%-69.86%-57.55%-93.9%-76.01%
Operating CF Growth %-19.31%100%9.2%--64.48%-124.97%---
Net Income-21.89M-13.47M-14.21M-16.87M-28.66M-18.11M-9.74M-12.45M-18.85M
Depreciation & Amortization671K0683K653K604K529K0563K544K
Stock-Based Compensation5.41M4.3M4.48M4.8M2.8M1.55M01.36M1.58M
Deferred Taxes000000000
Other Non-Cash Items200K9.16M2K-678K11.74M4.99M1.46M3.27M10.95M
Working Capital Changes-8.21M0317K-1.5M-6.47M-3.24M-1.34M-4.88M-566K
Change in Receivables1.37M0-168K-2.33M2.94M-4.56M1.5M-1.92M-2.48M
Change in Inventory-1.8M0-3.33M-1.73M-2.62M-1.58M-3.56M-2.41M-916K
Change in Payables-3.33M01.1M568K-97K-60K105K410K680K
Cash from Investing21.84M09.49M6.17M-179.12M-29.66M15.24M7.64M-69.61M
Capital Expenditures-1.38M0-1.28M-1.78M-333K-561K-1.92M-406K-313K
CapEx % of Revenue4.98%-4.7%7.66%1.89%2.74%11.5%3.14%3.75%
Acquisitions000000050K0
Investments---------
Other Investing000000000
Cash from Financing623K02.65M42K211.12M56.89M-1.18M6K9K
Debt Issued (Net)000000000
Equity Issued (Net)623K02.65M42K211.02M56.89M-1.29M6K9K
Dividends Paid000000000
Share Repurchases000000000
Other Financing000098K0119K00
Net Change in Cash-1.37M-38.59M3.41M-7.38M12.02M12.95M17.48M-4.49M26.57M
Free Cash Flow-25.21M0-10.01M-15.37M-20.31M-14.84M-11.53M-12.55M-6.66M
FCF Margin %-91.25%--36.73%-66.15%-115.13%-72.6%-69.05%-97.04%-79.76%
FCF Growth %-24.13%100%13.2%--61.82%-122.82%---
FCF per Share-0.57--0.23-0.35-0.66-0.34-0.27-0.41-1.10
FCF Conversion (FCF/Net Income)1.09x-0.61x0.81x0.70x0.79x0.99x0.98x0.34x
Interest Paid000000000
Taxes Paid000000000